December 2017 #VTEonSoMe Twitter Chat—Let’s Talk Blood Clots! Surgeries, Birth Control, and 40+
By: Taylor Pecko-Reid
December 12, 2017
Join us Wednesday, December 20, at 3 pm CT as we discuss all things venous thromboembolism (VTE). Physicians and experts from CHEST, the American Osteopathic Association, and MedPage Today will participate during the #VTEonSoMe Twitter chat.
Have you recently had surgery, are you 40+, or do you take oral contraceptives? In our #VTEonSoMe chat, we’ll share how these factors affect your risk of a blood clot that forms in a vein deep inside the body that blocks important blood flow—known as venous thromboembolism (VTE)—and how to manage that risk.
Affecting an estimated 350,000 to 600,000 Americans each year, the #VTEonSoMe (venous thromboembolism on social media) campaign sheds light on deep vein thrombosis (DVT) and pulmonary embolism (PE). In 2017, the CHEST Foundation campaign shed light on VTE. Because VTE can affect almost anyone, CHEST believes it’s important to provide information for proper diagnosis, treatment, and care to the public. Over the past few months we’ve hosted Facebook Live videos with Dr. Timothy Morris and Dr. Barbara Levy, held a Reddit Science AMA discussion on blood clots with Dr. Lisa K. Moores, and launched a social campaign to raise awareness on the disease state.
This time around, we’d like to hear from you! We’re partnering with Dr. Hassan Bencheqroun, the American Osteopathic Association, and MedPage Today for our #VTEonSoMe Twitter chat! During our December chat, we’ll discuss all things VTE. Have you recently had surgery, are you 40+, or do you take oral contraceptives? During this chat, we’ll share how these patients are at higher risk for VTE and how to manage risks.
We hope you will join us on Wednesday, December 20, at 3 pm CT.
Topics:
T1: How can we lessen risk of the major risk factors for developing VTE?
T2: What are the warning signs that should prompt medical attention, and how is VTE diagnosed?
T3: What are the latest treatment options for patients with VTE?
T4: What measures can patients take to avoid developing new blood clots?
Further Research